-
Taigexyn®
- Discovery Research
- Preclinical
I
Phase
II
Phase
III
Phase
- NDA
- Marketed
- Community Acquired Pneumonia (Oral) Taiwan IND
- Community Acquired Pneumonia (I.V.) Taiwan IND
- Community Acquired Pneumonia (Oral) China IND
- Community Acquired Pneumonia (I.V.) China IND
- Community Acquired Pneumonia (I.V.) Russia IND
- CAP / Diabetic Foot Infection (Oral) US IND
-
TG-1000
- Discovery Research
- Preclinical
I
Phase
II
Phase
III
Phase
- NDA
- Marketed
- Influenza A, B US / China IND
-
Furaprevir
- Discovery Research
- Preclinical
I
Phase
II
Phase
III
Phase
- NDA
- Marketed
- HCV (Furaprevir) US / Taiwan IND
- HCV (Furaprevir+Imitasvir) China IND
-
Burixafor
- Discovery Research
- Preclinical
I
Phase
II
Phase
III
Phase
- NDA
- Marketed
- Stem Cell transplantation US IND
- Chemosenzitization China IND